Report Overview
Endocrinology is the internal medicine subspecialty dedicated to the diagnosis and care of diseases and conditions related to the endocrine glands, hormones, and metabolism, the body?s physical and chemical processes to use energy or convert it for use. These diseases and conditions include type 1 and type 2 diabetes; obesity; conditions of the pituitary, thyroid, parathyroid, and adrenal glands; and metabolic disorders.
The global Endocrinology and Metabolism market was valued at 77730 million in 2023 and is projected to reach US$ 173930 million by 2030, at a CAGR of 12.1% during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Endocrinology and Metabolism, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocrinology and Metabolism. This report contains market size and forecasts of Endocrinology and Metabolism in global, including the following market information:
Global Endocrinology and Metabolism market revenue, 2019-2024, 2025-2030, ($ millions)
Global top five Endocrinology and Metabolism companies in 2023 (%)
The rising frequency of endocrine problems, including diabetes, thyroid disorders, and hormonal imbalances, is another major factor driving the endocrinology and metabolism market. Sedentary lifestyles, bad eating habits, rising obesity rates, and an aging population all contribute to the growing global burden of endocrine illnesses. As the frequency and prevalence of these problems rise, so does the demand for diagnostic tests, medicines, and treatment procedures that address endocrine and metabolic abnormalities. This spike in demand opens up attractive prospects for market players to offer innovative products and services to meet the growing healthcare needs of people with endocrine diseases.
Prospect Research Reports (PRR) has surveyed the Endocrinology and Metabolism companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
Total Market by Segment:
Global Endocrinology and Metabolism market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Endocrinology and Metabolism market segment percentages, by Type, 2023 (%)
Diabetes Drugs
HGH
Thyroid Hormone Disorders
Others
Global Endocrinology and Metabolism market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Endocrinology and Metabolism market segment percentages, by Application, 2023 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Endocrinology and Metabolism market, by region and country, 2019-2024, 2025-2030 ($ millions)
Global Endocrinology and Metabolism market segment percentages, by region and country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Endocrinology and Metabolism revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Endocrinology and Metabolism revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Acerus Pharmaceuticals Corp.
Ascendis Pharma AS
Bayer AG
Beta Cell NV
Biocon Ltd.
Eli Lilly and Co.
Endo International Plc
Hoffmann La Roche Ltd.
GlaxoSmithKline Plc
Hanmi Pharm Co. Ltd.
Ipsen Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Endocrinology and Metabolism, market overview.
Chapter 2: Global Endocrinology and Metabolism market size in revenue.
Chapter 3: Detailed analysis of Endocrinology and Metabolism company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Endocrinology and Metabolism in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
